Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Active, not recruiting · NCT04137562 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-06-22 | NCT04137562 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EHL Bio Co., Ltd. | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chung-Ang University Hospital | Seoul | South Korea | 1 |
| Chungnam National University Hospital | Daejeon | South Korea | 1 |
| Korea University Ansan Hospital | Ansan | South Korea | 2 |
| Kyunghee University Medical Center | Seoul | South Korea | 1 |
| Seoul National University Hospital | Seoul | South Korea | 1 |
| SMG-SNU Boramae Medical Center | Seoul | South Korea | 1 |